Journal Review in Surgical Oncology_ Neuroendocrine Tumors of the Small Bowel

  • Join the Behind the Knife Surgical Oncology Team as we discuss the two key studies investigating optimal management strategies of neuroendocrine tumors of the small bowel!

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physician Assistants

Learning Objectives

  1. Discussing the NETTER-2 trial investigating the role of radioligand therapy for NET as a first-line treatment as outlined in the first paper by Singh and colleagues   
  2. Outlining the challenges described in the second article by Maxwell et al that describes surgical dogma regarding optimal debulking cutoffs for debulking of NET
  3. Discussing the rationale for surgical debulking of metastatic neuroendocrine tumors, including the goal of achieving at least a 70% tumor reduction to improve survival outcomes
Course summary
Available credit: 
  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.50 ANCC
  • 0.50 Attendance
  • 0.50 JA Credit - AH
    • 0.50 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
07/15/2025
Registration Expires: 
07/14/2027
Part of: 
Behind the Knife Podcast (2025)
Rating: 
0
Virtual, NC 27705
United States
  • Timothy Vreeland, MD, 
  • Daniel Nelson, DO
  • Connor Chick, MD 
  • Lexy (Alexandra) Adams, MD, MPH
  • Beth (Elizabeth) Barbera, MD
  • AMA PRA Category 1 Credit(s)
  • ANCC
  • Attendance
  • JA Credit - AH

Available Credit

  • 0.50 AMA PRA Category 1 Credit(s)™
  • 0.50 ANCC
  • 0.50 Attendance
  • 0.50 JA Credit - AH
    • 0.50 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.